Audience Q&A and closing remarks

29 August 2025 (10:40 - 10:45)

Organised by:

About the speakers

Doctor Sneha Jain

Stanford Health Care, Palo Alto (United States of America)

Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

Professor Davide Capodanno

University of Catania, Catania (Italy)

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail

Welcome

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Stroke prevention in atrial fibrillation and MACE after acute coronary syndrome: prevalence and challenges

Professor D. Capodanno (Catania, IT)

Presentation thumbnail

Current treatments in atrial fibrillation and acute coronary syndrome, safety and guidelines

Doctor S. Jain (Palo Alto, US)

Presentation thumbnail

Targeting factor XI: innovations in anticoagulation

Doctor J. Weitz (Hamilton, CA)

Presentation thumbnail

Shaping clinical practice and clinical trials

Professor C. Lam (Singapore, SG)

Access the full session

Session thumbnail

Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies

The Event

Event poster

ESC Congress 2025

29 August 2025 10:40 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources